GAITHERSBURG, Md., May 19, 2026 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd”), a U.S.-based clinical-stage biotechnology company focused on women’s...
New sites in New Jersey, New York, and Florida broaden geographic reach and increase access for patients participating in Phase...
Increase in stockholder equity and note extension strengthen Company’s ability to advance pancreatic cancer development strategyOCALA, Fla., May 19, 2026...
WALTHAM, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company...
Veteran biotechnology executive with more than 20 years of leadership experience spanning research, clinical development, commercialization and company building Proven...
Veteran physician, medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience,...
CINCINNATI, Ohio, May 19, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company...
TRUE-See’s patented technology is designed to make medical photography accurate, reliable and easily accessibleNEW ORLEANS, May 19, 2026 (GLOBE NEWSWIRE)...
Webcast will be held Thursday, May 21, 2026, at 5:30 p.m. ET CAMBRIDGE, Mass., May 19, 2026 (GLOBE NEWSWIRE) --...
SUNNYVALE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a global leader in cellular and cell-derived therapeutics for the...
Patrick Hensley, MD and Daniel Joyce, MD, MS each received a grant up to $50,000.00 to support the development of...
TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Brain Cancer Canada (BCC), Canada’s only 100% volunteer-driven charity dedicated exclusively to funding...
MORRISVILLE, N.C., May 19, 2026 (GLOBE NEWSWIRE) -- Science 37 today announced the publication of a new analysis in Applied...
Trial liver safety data from the ‘ESSENCE’ trial confirm semaglutide's favourable hepatic profile in patients with Metabolic Dysfunction-associated Steatohepatitis (MASH),...
Garching / Munich, May 19, 2026 –– ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced...
Matisse production image Two workers in cleanroom Geleen, May 19th, 2026 Matisse Pharmaceuticals B.V., a clinical stage company developing a...
Leo International Precision Health AG: Total Voting Rights Announcement Release according to Article 41 of the WpHG with the objective...
Milestone advances commercial and manufacturing readiness ahead of anticipated pivotal study scale-upBURLINGTON, Mass, May 19, 2026 (GLOBE NEWSWIRE) -- Bone...
Partnership to deliver a novel AI-native integrated CNS oncology platform Platform will unify and analyze Plus’ proprietary therapeutic, diagnostic, and...
– Alterity’s novel imaging and biomarker approach positions the Company at the forefront of clinical research in MSA – –...